Retour
SANOFI-AVENTIS (EPA:SAN) Press Release: Sanofi announces change in R&D leadership
Directive transparence : information réglementée
13/02/2023 08:30
Tweeter
18/03/2023 15:00
Press Release: Dupixent® (dupilumab) late-breaking data at AAD show...
16/03/2023 21:06
Press Release: Sanofi cuts U.S. list price of Lantus®, its...
14/03/2023 19:27
Information concerning the total number of voting rights and shares –...
02/03/2023 08:00
Press Release: Completed XTEND-Kids Phase 3 study strengthens potential of...
24/02/2023 17:16
ALTUVIIIO™ approved by the U.S. FDA: this positive event triggers...
23/02/2023 22:00
Press Release: FDA approves once-weekly ALTUVIIIO™, a new class of...
13/02/2023 08:30
Press Release: Sanofi announces change in R&D leadership
03/02/2023 07:30
Press Release : Strong sales performance and double digit EPS growth...
17/01/2023 20:44
Sanofi: Information concerning the total number of voting rights and...
17/01/2023 20:27
Sanofi: Disclosure of trading in own shares
Voir tous les communiqués de SANOFI-AVENTIS